Tag: FDA approval
August 19, 2018
5 Top Weekly NASDAQ Biotech Stocks: Idera Rises to the Top
Idera Pharmaceuticals, Eiger Biopharma, Aevi Genomic Medicine, Evofem Biosciences and Biospecifics Tech were last week's top gainers on the NASDAQ... August 17, 2018
Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
Antares Pharma (NASDAQ:ATRS) announced that the U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical, epinephrine auto injector drug-device...
August 13, 2018
Alynlam Pharma Receives FDA Approval for Onpattro
On Friday, Alnylam Pharmaceuticals received US Food and Drug Administration approval for Onpattro (patisiran). August 13, 2018
Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis
Arbutus Biopharma (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that the Company’s lipid nanoparticle (LNP)... August 12, 2018
5 Top Weekly NASDAQ Biotech Stocks: Vericel Takes Top Spot
Vericel, AcelRx, Tetraphase Pharmaceuticals, KalVista and Infinity Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: resTORbio Leads the Pack
resTORbio, ADMA Biologics, Misonix, Novus Therapeutics and Innovate Biopharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index. July 24, 2018
EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
EyeGate Pharmaceuticals (NASDAQ:EYEG) has announced that the US Food and Drug Administration (FDA) has approved two of the company’s Investigational...
July 18, 2018
Novartis Notches First FDA Nod Through New Oncology Review Pilot
Novartis' Kisqali drug is the first approved by the US Food and Drug Administration (FDA) under its new oncology drug... July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ... July 11, 2018